Resources

Selected
  • Systematic reviews (SYSVAC)
  • Pregnant women
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
246 results found
2025 ∙ Dakiniewich, A. Graham, S. Dyda, A. McHugh, L.
Pregnancy loss <28 weeks gestation in maternal influenza and COVID-19 vaccination studies: a review of data sources, 2009-2024
Pregnant women COVID-19 Influenza Safety
Rating:
Critically low
2025 ∙ Trusinska, D. Lee, B. Ferdous, S. Kwok, H. H. Y. Gordon, B. Gao, J. Ma, L. Xiong, H. Sheikh, S. A. Schwarze, J. Busby, J. Gibbons, C. Drysdale, S. B. Ritchie, S. L. Williams, T. Shi, T.
Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis
Newborn Children Adults Older adults Pregnant women RSV (Respiratory syncytial virus) Coverage
Rating:
Not applicable
2025 ∙ Deese, J. Schaible, K. Massierer, D. Tingir, N. Fell, D. B. Atwell, J. E.
Systematic Literature Review of Maternal Antibodies in Human Milk Following Vaccination During Pregnancy or Lactation Tetanus, Pertussis, Influenza and COVID-19
Pregnant women Tetanus Pertussis Influenza COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Regan, A. K. Uwimana, H. Rowe, S. L. Olsanska, E. J. Agnew, B. Castillo, E. Fiddian-Green, A. Giles, M. L.
Systematic review and meta-analysis of interventions to increase the uptake of vaccines recommended during pregnancy
Pregnant women Coverage
Rating:
Not applicable
2025 ∙ Tinessia, A. Sabahelzain, M. M. King, C. Khalatbari-Soltani, S. Gunaratnam, P. Dadari, I. Lorenzo, J. C. Bhaumik, S. Sheel, M.
Systematic review of pro-equity strategies to improve vaccination among priority populations
All age groups Pregnant women Healthcare workers Parents/caregivers Coverage Ethical issues
Rating:
Not applicable
2025 ∙ Lei, Z. J. Bai, M. X. Li, M. J. Jin, P. Ding, Y. B.
The Effectiveness and Influence of COVID-19 Vaccination on Perinatal Individuals and Their Newborns: An Updated Meta-Analysis
Pregnant women COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Bardach, A. Brizuela, M. Berrueta, M. Ciapponi, A. Sambade, J. M. Ballivian, J. Ortega, V. Castellana, N. Comande, D. Parker, E. P. K. Kampmann, B. Stegelmann, K. Xiong, X. Stergachis, A. Munoz, F. M. Buekens, P. Mazzoni, A.
Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines
Pregnant women Newborn Children Adolescents Chikungunya Safety
Rating:
Not applicable
2025 ∙ Jafari, Z. Kolb, B. E. Aiken, S. Wilson, S.
Updates on Auditory Outcomes of COVID-19 and Vaccine Side Effects: An Umbrella Review
All age groups Pregnant women COVID-19 Safety
Rating:
Not applicable
2025 ∙ Riches, N. Henrion, M. Y. R. MacPherson, P. Hahn, C. Kachala, R. Mitchell, T. Murray, D. Mzumara, W. Nkoka, O. Price, A. J. Riches, J. Seery, A. Thom, N. Loarec, A. Lemoine, M. Ndow, G. Shimakawa, Y. Thompson, P. Morgan, C. Desai, S. Easterbrook, P. Stockdale, A. J.
Vertical transmission of hepatitis B virus in the WHO African region: a systematic review and meta-analysis
Africa Pregnant women Newborn Hepatitis B Efficacy/effectiveness Coverage
Rating:
Not applicable
2024 ∙ Uta, M. Craina, M. Marc, F. Enatescu, I.
Assessing the Impact of COVID-19 Vaccination on Preterm Birth: A Systematic Review with Meta-Analysis
Pregnant women COVID-19 Safety
Rating:
Low
Loading...